Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Anti-HBs Antibodies with HB-AS02V vs Fendrix in Renal Patients
NCT00445185Phase 3Completed
- Sponsor
- Henogen
- Start
- Mar 2007
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of adjuvanted hepatitis B vaccine HB-AS02V in hepatitis B (HBV), sponsored by Henogen. Started Mar 2007; status: completed.
02
Drugs
adjuvanted hepatitis B vaccine HB-AS02V
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00445185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445185.